Noriko Motoi
Saitama Cancer Center(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, RNA modifications and cancer
Most-Cited Works
- → MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited
- → Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study(2008)1,237 cited
- → Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases(2011)990 cited
- → Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas(2007)659 cited
- → A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee(2020)521 cited
- → EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset(2009)443 cited
- → IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy(2020)427 cited
- → Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer(2017)397 cited
- → Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis(2008)373 cited
- → Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study(2019)366 cited